Sarepta Therapeutics Inc (NASDAQ:SRPT)
| 124.40 Delayed Data As of 3:59pm ET |  +1.13 / +0.92%Today’s Change | 61.28 Today|||52-Week Range 134.08 | -4.00% Year-to-Date |
Latest SRPT News | Press Releases
No recent news for Sarepta Therapeutics Inc.
Today’s Trading
| Previous close | 123.27 |
| Today’s open | 123.59 |
| Day’s range | 122.30 - 125.08 |
| Volume | 26,669 |
| Average volume (3 months) | 963,733 |
| Market cap | $11.4B |
Data as of 3:59pm ET, 01/26/2023
Growth & Valuation
| Earnings growth (last year) | +27.50% |
| Earnings growth (this year) | -56.65% |
| Earnings growth (next 5 years) | +67.30% |
| Revenue growth (last year) | +29.96% |
| P/E ratio | NM |
| Price/Sales | 10.43 |
| Price/Book | 12.21 |
Competitors
Data as of 3:59pm ET, 01/26/2023
Financials
| Next reporting date | February 28, 2023 |
| EPS forecast (this quarter) | -$1.45 |
| Annual revenue (last year) | $701.9M |
| Annual profit (last year) | -$418.8M |
| Net profit margin | -59.66% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
